CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN PREVENTION OF CISPLATIN-INDUCED EMESIS

被引：1
|
作者：
EGROS, F
DUFOUR, A
CAZOR, JL
机构：
来源：
LANCET | 1992年 / 340卷 / 8819期
关键词：
D O I：
10.1016/0140-6736(92)92161-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 619
页数：1
相关论文
共 50 条
  • [41] HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND INTERMITTENT INTRAMUSCULAR PROCHLORPERAZINE AND DIAZEPAM IN THE MANAGEMENT OF EMESIS INDUCED BY CIS-DICHLORODIAMMINEPLATINUM
    LUESLEY, DM
    TERRY, PB
    CHAN, KK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (03) : 250 - 252
  • [42] Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study
    Roila, F.
    Ruggeri, B.
    Ballatori, E.
    Fatigoni, S.
    Caserta, C.
    Licitra, L.
    Mirabile, A.
    Ionta, M. T.
    Massidda, B.
    Cavanna, L.
    Palladino, M. A.
    Tocci, A.
    Fava, S.
    Colantonio, I.
    Angelelli, L.
    Ciuffreda, L.
    Fasola, G.
    Zerilli, F.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1248 - 1253
  • [43] IMPROVED CONTROL OF CISPLATIN-INDUCED EMESIS WITH A METOCLOPRAMIDE-DEXAMETHASONE COMBINATION
    COGNETTI, F
    PINNARO, P
    CARLINI, P
    CAPORALI, C
    RUGGERI, EM
    POLLERA, CF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) : 235 - 237
  • [44] COMPARISON OF THE 5-HYDROXYTRYPTAMINE3 (SEROTONIN) ANTAGONIST ONDANSETRON (GR-38032F) WITH HIGH-DOSE METOCLOPRAMIDE IN THE CONTROL OF CISPLATIN-INDUCED EMESIS
    MARTY, M
    POUILLART, P
    SCHOLL, S
    DROZ, JP
    AZAB, M
    BRION, N
    PUJADELAURAINE, E
    PAULE, B
    PAES, D
    BONS, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12): : 816 - 821
  • [45] Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis
    Basurto, C
    Ciccarese, G
    Palladino, MA
    Picciafuoco, M
    Ricci, S
    Antonuzzo, A
    Allegrini, G
    Conte, PF
    Cognetti, F
    Cirulli, S
    Colella, E
    Milella, M
    Savarese, A
    Stani, S
    Contu, A
    Olmeo, N
    Piro, S
    Piras, M
    Pilo, L
    Pilo, P
    Nuzzo, A
    Ursini, LA
    Taraborrelli, M
    Melena, S
    Basilico, L
    Buzzi, F
    Brugia, M
    Trippa, F
    DelRio, S
    Tagliaventi, M
    Picece, V
    Cassandrini, P
    Cirillo, M
    Magarotto, R
    Recaldin, E
    Clerico, M
    Bartetto, O
    Morandini, MP
    Bainotti, L
    Boni, C
    Moretti, G
    Savoldi, L
    Tateo, S
    Chiapparini, I
    Zara, C
    Catalano, G
    Cascinu, S
    Alessandroni, P
    Massidda, B
    Ionta, MT
    ANNALS OF ONCOLOGY, 1995, 6 (08) : 805 - 810
  • [46] SINGLE-AGENT ORAL GRANISETRON FOR THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS - A DOUBLE-BLIND, RANDOMIZED COMPARISON WITH GRANISETRON PLUS DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE
    HERON, JF
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 24 - 30
  • [47] Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy
    Bhatia, A
    Tripathi, KD
    Sharma, M
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2003, 118 : 33 - 41
  • [48] ONDANSETRON PLUS DEXAMETHASONE VS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN PREVENTION OF CISPLATIN-INDUCED EMESIS
    ROILA, F
    TONATO, M
    BALLATORI, E
    PAES, D
    DELFAVERO, A
    BASURTO, C
    BRACARDA, S
    CORGNA, E
    PICCIAFUOCO, M
    PATOIA, L
    FAVALII, G
    GARBELLI, R
    BIANCHI, UA
    SCARFONE, G
    FERRARIS, C
    BOLIS, MC
    COGNETTI, F
    CERCATO, A
    BUZZI, F
    DELRIO, S
    SABBATINI, R
    FEDERICO, M
    MATERA, G
    CELLERINO, R
    DAZZI, C
    MARANGOLO, M
    LEONARDI, M
    CANALETTI, R
    BABILONTI, L
    ZARA, C
    DONATI, D
    AMADORI, D
    FERRARI, M
    LANCET, 1992, 340 (8811): : 96 - 99
  • [49] IMPROVED BENEFIT RISK RATIO OF HIGHER-DOSE METOCLOPRAMIDE THERAPY DURING CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    HELLSTERN, A
    HESS, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (03) : 311 - 312
  • [50] A RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ALONE AND IN COMBINATION WITH INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF HIGH-DOSE CISPLATIN-INDUCED EMESIS
    HESKETH, PJ
    HARVEY, WH
    HARKER, WG
    BECK, TM
    RYAN, T
    BRICKER, LJ
    KISH, JA
    MURPHY, WK
    HAINSWORTH, JD
    HALEY, B
    PLAGGE, P
    FLACK, NE
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) : 596 - 600
12345